SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Beat the Market Biotechs
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Western Rookie3/15/2012 12:08:50 PM
   of 72
 
Biotech watchlist....


MDX-V MedX Health Corp - MoleMate - Skin Cancer Imaging System - Health Canada Approval simsys-molemate.com $7.8M market cap.

CFR-V Chemaphor - Oximunol chewables - Oxidized Beta Carotene - 3 Stage Commercialization... $7.5M market cap
  1. Animal health 2012
  2. Livestock Industry 2013 - potential to replace antibiotics in feed indsutry
  3. Human health 2014 - enhanced immune function

MOM-V Miraculins - PreVu POC Test - Reads skin Cholesterol and helps evaluate a patients risk for coronary Artery Disease CAD. FDA Approval $10M market cap.

SBM-V Sirona Biotech Corp - Specialize in producing carbohydrate based molecules. which maximizes the commercial value of carbohydrate based drugs. Apply technology across a diabetes therapeutics, cosmetic agents and biological ingredients. $7M market cap

VRS-V Verisante Technologies - Verisante Aura - Non-invasive cancer detection devices taht offer physicians immediate results for many common types of Cancer. $41.3M market cap

FLU-C Abattis Biologix - Neutraceutical product development company - Krill Oil / Nitric Oxide / DefenZall / FastFlu / Saskatoon Berries / Acai - $3.6M market cap


NTB-T Netpune Technologies and Bioressources Inc - NKO - Krill Oil. Company is purely krill oil. $151M market cap

APO-V Acasti Pharma Inc. - Neptune's pharma division developing safe and effective pharmaceutical and medical applications with an initial focus on cardiovascular disease by leveraging the intellectual property, clinical data and know how developed by Neptune Technologies. $155M market cap.

BTI-V biOasis Technologies - Transcend - combines Transcend with other drugs to break the Blood Brain Barrier. $49M market cap

KLH-V Stellar Biotechnologies - KLH - KLH is an important protein used in wide-ranging therapeutic and diagnostic markets. Vital component for vaccines (cancer, autoimmune and infectious disease) and an antigen for measuring immune status. $17.5M market cap
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News